EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Anti-oestrogens and bone






Annales d'Endocrinologie 56(6): 603-608

Anti-oestrogens and bone

Anti-oestrogens are a class of non-steroid compounds with, depending on the tissue, oestrogen-antagonist or oestrogen-agonist actions resulting from different mechanisms, especially by binding to oestrogen receptors. These compounds are commonly called anti-oestrogens because of their extensive use in treating breast cancer. Tamoxifen, the first of these complex compounds, has a partial agonist effect on the endometrium and also affects bone and lipid metabolism. Currently, our knowledge of anti-oestrogen action on bone is based on experimental work and a few clinical trials with tamoxifen. The animal studies show that tamoxifen has a preventive effect against bone hyper-remodelling resulting form ovariectomy in the rat. Most of the clinical studies, including the most recent, show that tamoxifen has no deleterious effect, and possibly even a moderate protective effect against bone loss, in menopaused women. This effect on bone tissue, together with lowered plasma cholesterol levels, has led to the development of other compounds with a bone and lipid agonist effect and secondary effects limited to endometrial hyperplasia. Third generation compounds include droloxifen keoxifen (or raloxifen) currently under investigation. This research should lead to wider indications for anti-oestrogens in the prevention of the effects of post-menopause oestrogen deficiency, particularly in patients with contraindications for oestrogen therapy.

(PDF 0-2 workdays service: $29.90)

Accession: 009770174



Related references

Local and parenteral action of oestrogens and anti-oestrogens on early pregnancy in the rat and mouse. Journal of Reproduction and Fertility 3: 239-245, 1962

The effects of oestrogens and anti-oestrogens on ovum transport in the laboratory mouse. Australian Journal of Biological Sciences 21(6): 1239-1248, 1968

Further studies on the effects of oestrogens and anti-oestrogens on early pregnancy in mice. Jour Reproduct And Fertility 5(2): 239-247, 1963

Cytoplasmic oestrogen receptor replenishment: oestrogens versus anti-oestrogens. Acta Endocrinologica 89(3): 599-611, 1978

Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. Journal of Steroid Biochemistry and Molecular Biology 37(6): 747-751, 1990

Action of oestrogens and anti-oestrogens on early pregnancy in the rabbit. Journal of Reproduction and Fertility 3: 246-249, 1962

The effects of oestrogens and anti-oestrogens on early pregnancy in mice. Journal of Endocrinology 20: 299-306, 1960

Oestrogens and anti-oestrogens in feeds. 2. Use of a biological screeningtest for samples of lucerne, grass, maize and chinchilla feed. Ztschr. Tierphysiol. Tierernahrung Futtermittelk, 25: 248-256, 1969

Oestrogens and anti-oestrogens show dissociation between early uterine vascular responses and uterotrophic effects in mice. Acta Endocrinologica 100(2): 290-294, 1982

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations. British Journal of Cancer 94(7): 1021-1028, 2006